Top compounds associated with response to UBE2G1


Feature Type Standardized
Nominal ANOVA
mRNA YM-155 CTRPv2 pan-cancer AAC 0.22 2e-08
mRNA Doxorubicin gCSI pan-cancer AAC 0.27 3e-07
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.17 6e-07
mRNA Rapamycin gCSI pan-cancer AAC 0.27 1e-06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA TW 37 GDSC1000 pan-cancer AAC 0.15 8e-06
Download CSV